Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$19.5M
+25.4% from 2023
Prescriptions
4,260
$4,581.55 per claim
Patients
1,122
1,096 prescribers
Total spending, 2024
$19.5M
$17,393.95 per patient
Medicare prescription drug plans paid $19.5M for Avycaz in 2024, for 4,260 prescriptions and refills to 1,122 patients (up 25.4% from 2023). The average cost per claim was $4,581.55.
California had the highest Medicare cost for Avycaz in 2024: $2.3M for 510 claims, followed by Ohio ($1.6M).
Leah Turner, nurse practitioner in Philadelphia, PA, had the highest Medicare cost for Avycaz in 2024: 52 claims costing $433K.
Avycaz is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Allergan Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Leah Turner Philadelphia, PA | Nurse Practitioner | 52 | Under 11 | $433K |
| Rigel Galera Port Huron, MI | Family Practice | 13 | Under 11 | $413K |
| Ashley A Lipps Columbus, OH |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 817 | 3,185 | 820 | $12.7M |
| 2023 | 853 | 3,414 | 886 | $15.6M |
| 2024 | 1,096 | 4,260 | 1,122 | $19.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 31 |
| Under 11 |
| $355K |
| Paul F Kamitsuka Wilmington, NC | Infectious Disease | 26 | Under 11 | $222K |
| Valentina Stosor Chicago, IL | Infectious Disease | 19 | Under 11 | $184K |
| See-Ruern S Kitt Bakersfield, CA | Infectious Disease | 26 | Under 11 | $177K |
| Mohamed H Hasham Old Bridge, NJ | Infectious Disease | 20 | Under 11 | $153K |
| Zhi J Yu Jacksonville, FL | Family Practice | 40 | Under 11 | $151K |
| Doreen Addrizzo-Harris New York, NY | Internal Medicine | 31 | Under 11 | $141K |
| Shirisha Pasula Fresno, CA | Internal Medicine | 18 | Under 11 | $138K |
| Deepika Buchupalli Joliet, IL | Infectious Disease | 18 | Under 11 | $134K |
| James C Demidovich Canfield, OH | Family Practice | 29 | Under 11 | $130K |
| Brendan K Sweeny Greenwood, IN | Family Practice | 31 | Under 11 | $121K |
| Anne Friedland Baltimore, MD | Infectious Disease | 22 | Under 11 | $117K |
| Agnes K Kresch Green Bay, WI | Infectious Disease | 15 | Under 11 | $116K |
| Markian R Bochan Carmel, IN | Infectious Disease | 11 | Under 11 | $115K |
| Tejal N Gandhi Ann Arbor, MI | Infectious Disease | 19 | Under 11 | $105K |
| Katherine Krantz Miami, FL | Nurse Practitioner | 13 | Under 11 | $86K |
| Rania Aboujaoude Browns Mills, NJ | Infectious Disease | 35 | Under 11 | $79K |
| Patricia Bartley Cleveland, OH | Infectious Disease | 15 | Under 11 | $75K |
| Joanna Kopacz Laguna Hills, CA | Infectious Disease | 12 | Under 11 | $74K |
| Nakeisha A Otto-Stewart Colquitt, GA | Family Practice | 15 | Under 11 | $72K |
| Rachel Gnanaprakasam Bedford, TX | Infectious Disease | 11 | Under 11 | $71K |
| Erika Granda Morristown, NJ | Internal Medicine | 32 | Under 11 | $69K |
| Karen B Saylor Mount Vernon, KY | Internal Medicine | 13 | Under 11 | $69K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Allergan Inc. ABBV | 4,263 | $19.5M |